• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 144-158 of 276 results

2038 Exhibit: Ex2038 Lumigan 003 Label

Document IPR2017-01434, No. 2038-68 Exhibit - Ex2038 Lumigan 003 Label (P.T.A.B. Mar. 5, 2018)

cite Cite Document
Analyze

1011 Exhibit: Exhibit 1011 Nixon, D ¿¿¿Hyperemia in Glaucoma Patients

Document IPR2017-01434, No. 1011-11 Exhibit - Exhibit 1011 Nixon, D ¿¿¿Hyperemia in Glaucoma Patients (P.T.A.B. May. 12, 2017)

cite Cite Document
Analyze

1039 Exhibit: Camras et al, ¿¿¿Latanoprost, a Prostaglandin Analog, for Glaucoma T...

Document IPR2017-01434, No. 1039-87 Exhibit - Camras et al, ¿¿¿Latanoprost, a Prostaglandin Analog, for Glaucoma Therapy efficacy and safety after 1 year of treatment in 198 patients,¿¿¿ Ophthalmology...

cite Cite Document
Analyze

1046 Exhibit: Husain S et al, ¿¿¿Latanoprost Induced Changes in Rat IntraocularPre...

Document IPR2017-01434, No. 1046-94 Exhibit - Husain S et al, ¿¿¿Latanoprost Induced Changes in Rat IntraocularPressure Direct or Indirect ¿¿¿ J Ocul Pharmacol Ther, 244367¿¿¿372 2008 (P.T.A.B. Jun. 5...

cite Cite Document
Analyze

2035 Exhibit: Ex2035 Aung 2001

Document IPR2017-01434, No. 2035-65 Exhibit - Ex2035 Aung 2001 (P.T.A.B. Mar. 5, 2018)

cite Cite Document
Analyze

1027 Exhibit: Exhibit 1027 Declaration of Mitchell deLong, PhD

Document IPR2017-01434, No. 1027-27 Exhibit - Exhibit 1027 Declaration of Mitchell deLong, PhD (P.T.A.B. May. 12, 2017)

cite Cite Document
Analyze

2053 Exhibit: Ex 2053 Tafluprost PMDA Entry

Document IPR2017-01434, No. 2053-122 Exhibit - Ex 2053 Tafluprost PMDA Entry (P.T.A.B. Aug. 9, 2018)

cite Cite Document
Analyze

2047 Exhibit: Ex2047 Dunitz 1997

Document IPR2017-01434, No. 2047-77 Exhibit - Ex2047 Dunitz 1997 (P.T.A.B. Mar. 5, 2018)

cite Cite Document
Analyze

2051 Exhibit: Ex 2051 WestLaw Version of Alcon Canada v Apotex

Document IPR2017-01434, No. 2051-120 Exhibit - Ex 2051 WestLaw Version of Alcon Canada v Apotex (P.T.A.B. Aug. 9, 2018)

cite Cite Document
Analyze

2058 Exhibit: Ex 2058 Rulo 1994

Document IPR2017-01434, No. 2058-113 Exhibit - Ex 2058 Rulo 1994 (P.T.A.B. Jul. 26, 2018)

cite Cite Document
Analyze

2061 Exhibit: Ex 2061 deLong Transcript II

Document IPR2017-01434, No. 2061-116 Exhibit - Ex 2061 deLong Transcript II (P.T.A.B. Jul. 26, 2018)

cite Cite Document
Analyze

2060 Exhibit: Ex 2060 Xalatan label, Nov 26, 2001

Document IPR2017-01434, No. 2060-115 Exhibit - Ex 2060 Xalatan label, Nov 26, 2001 (P.T.A.B. Jul. 26, 2018)

cite Cite Document
Analyze

1017 Exhibit: Exhibit 1017 Patent and Exclusivity for N202514 ZIOPTAN

Document IPR2017-01434, No. 1017-17 Exhibit - Exhibit 1017 Patent and Exclusivity for N202514 ZIOPTAN (P.T.A.B. May. 12, 2017)

cite Cite Document
Analyze

2014 Exhibit: Ex 2014 Villumsen 1990

Document IPR2017-01434, No. 2014-42 Exhibit - Ex 2014 Villumsen 1990 (P.T.A.B. Sep. 7, 2017)

cite Cite Document
Analyze

2021 Exhibit: Ex 2021 Klimko 2004

Document IPR2017-01434, No. 2021-49 Exhibit - Ex 2021 Klimko 2004 (P.T.A.B. Sep. 7, 2017)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 10 11 12 13 14 ... 17 18 19 >>